CD14 and myeloid sarcoma: Interestingly, the levels of leukocyte CD45+ (Protein Tyrosine Phosphatase Receptor Type C) and monocyte CD14+ (monocyte differentiation antigen CD14)-labelled EVs increased both in RRMS and SPMS, but not in untreated MS patients.